A. Einarson, C. Maltepe, Y. Navioz
Sep 1, 2004
Citations
5
Influential Citations
200
Citations
Quality indicators
Journal
BJOG: An International Journal of Obstetrics & Gynaecology
Abstract
Objective Ondansetron (Zofran) is a drug used for the treatment of nausea and vomiting caused by cancer chemotherapy. Despite the fact that it is not indicated, women are being prescribed this drug for the treatment of nausea and vomiting of pregnancy (NVP). There is a paucity of information on fetal safety for this indication. The objective of this study is to determine whether this drug increases the baseline rate of major malformations.